Investment Thesis
3BFuture Health Fund invests in US, European, and Israeli startups focused on life-changing treatments, prioritizing oncology and rare diseases with strong unmet patient needs. The fund targets companies with robust science, experienced management, and potential for transformative impact.
Stage Focus
Series A and earlier-stage investments
Preferred startup development maturity for initial funding deployment.
Sectors & Themes
Early-stage and clinical development-stage companies with first-in-class assets, revolutionary insights, and unmet patient needs
Core thematic spaces, technologies, and target market segments of interest.
Check Size Range
€11,040,000 - €11,040,000
Standard financial allocation per investment round.
Outreach & Dossier Intelligence
Direct Verification Contact Email Pattern
Thesis Dossier Analysis Scorecard
Our agent analyzer scanned portfolio holdings and verified absolute match parameters...
